H. Kantarjian
- Hematology top 0.2%
- Genetics top 0.2%
- Molecular Biology top 10%
- Public Health, Environmental and Occupational Health top 2%
- Rheumatology top 1%
- Co-authors
- Moshe TalpazJörge E. CortesCharles KollerElihu H. EsteyEmil J. FreireichMichael J. KeatingAndreas HochhausK. B. McCredie
- Topics
- Chronic Lymphocytic Leukemia Research (54 papers)Acute Myeloid Leukemia Research (51 papers)Chronic Myeloid Leukemia Treatments (46 papers)
- Cited by
- HematologyGeneticsRheumatology
- Partner nations
- United StatesFranceGermany
In The Last Decade
H. Kantarjian
112 papers receiving 3.8k citations
Peers
Comparison fields: 5 of 88
- Hematology 2.4k
- Genetics 2.1k
- Molecular Biology 995
- Public Health, Environmental and Occupational Health 781
- Rheumatology 776
Countries citing papers authored by H. Kantarjian
This map shows the geographic impact of H. Kantarjian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Kantarjian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Kantarjian more than expected).
Fields of papers citing papers by H. Kantarjian
This network shows the impact of papers produced by H. Kantarjian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Kantarjian. The network helps show where H. Kantarjian may publish in the future.
Co-authorship network of co-authors of H. Kantarjian
This figure shows the co-authorship network connecting the top 25 collaborators of H. Kantarjian. A scholar is included among the top collaborators of H. Kantarjian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Kantarjian. H. Kantarjian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 3 | |
| 7 | 1 | |
| 8 | 164 | |
| 9 | 116 | |
| 10 | 29 | |
| 11 | 118 | |
| 12 | 28 | |
| 13 | 11 | |
| 14 | 16 | |
| 15 | 9 | |
| 16 | 7 | |
| 17 | 126 | |
| 18 | 58 | |
| 19 | 73 | |
| 20 | 206 |
About H. Kantarjian
H. Kantarjian is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 120 papers that have together received 3.9k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (54 papers), Acute Myeloid Leukemia Research (51 papers) and Chronic Myeloid Leukemia Treatments (46 papers). The work is most often cited by research in Hematology (2.4k citations), Genetics (2.1k citations) and Rheumatology (776 citations). H. Kantarjian has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Moshe Talpaz, Jörge E. Cortes, Charles Koller, Elihu H. Estey, Emil J. Freireich, Michael J. Keating, Andreas Hochhaus, K. B. McCredie, Guillermo Garcia‐Manero and Timothy P. Hughes. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.